Screaming Buys: 2 Value Stocks That Increased Their Dividends

This pair of value stocks are screaming buys following their impressive quarterly results and dividend hikes.

| More on:
sale discount best price

Image source: Getty Images

This year has been tremendously upsetting for stock investors because market rallies are few and far between. Canada’s primary stock exchange has been shaky due to geopolitical tensions, supply chain disruptions, and inflationary pressures. Despite closing above 20,000 for the first time in more than two months on August 12, 2022, the TSX remains vulnerable.

However, during times of uncertainty, mediocre stocks take the back seat while quality stocks emerge. If you’re after value-for-money, Exchange Income Corporation (TSX:EIF), or EIC, and Medical Facilities (TSX:DR) are screaming buys today. Both companies reported impressive financial results in Q2 2022 and announced dividend increases.

Solid revenue and earnings growth

EIC investors are more than satisfied with their stock’s 19.8% positive return year to date amid the uncertainties. Its CEO, Mike Pyle, said, “The work you do in the past defines your future. Throughout the pandemic EIC stayed true to its business model, maintaining a strong balance sheet, investing in its companies, acquiring companies that meet our criteria and empowering our people.”

The $2 billion company has two core business segments, namely Aerospace & Aviation and Manufacturing. In Q2 2022, EIC achieved several milestones. The $529 million revenue and $30 million in net earnings were both record highs in the quarter, up 64% and 82%, respectively, versus Q2 2021.

Also, during the quarter, management increased its dividend (second consecutive quarter) by $0.12 per annum to $2.52. If you invest today ($48.93 per share), the dividend yield is a hefty 4.9%.

A cut above the rest  

Medical Facilities is a cut above the rest, considering that health care (-47.9%) is the worst-performing sector as of Friday last week. This health care stock is actually outperforming the broader market, up 11.5% versus a decline of -4.9% for the TSX year to date. Also, at $10.25 per share, the dividend yield is a decent 3.14%.

The $331.7 million company operates in the United States and owns a diverse portfolio of high-rated, high-quality surgical facilities. Currently, its controlling interests are in four specialty surgical hospitals and one ambulatory surgery centre. Moreover, the ownership stakes in five more ambulatory surgery centres are in partnership with NueHealth LLC.

Medical Facilities has a unique setup because the company partners with physicians who have a say in operations. In the first half of 2022, total revenue and other income increased by 4.5% to $196.3 million versus the same period in 2021. While net income in FH 2022 declined 4.7% year over year, net income in Q2 2022 versus Q2 2021 jumped 87.6% to US$22.2 million.

Robert O. Horrar, President and CEO of Medical Facilities, said, “Our surgical case volumes continued to improve in the quarter, particularly in the month of June, when volumes exceeded June 2021 volumes by 8.1% and June 2019, which was before the pandemic, by 8.9%.”

However, higher labor costs and other operating expenses had an impact on profitability. Still, Horrar assures that cash flow and the balance sheet remain strong. During the quarter, management raised its dividend by 3.7% (annualized yield).

Undervalued

Dividend-paying value stocks Exchange Income and Medical Facilities deserve serious consideration. Despite the outperformance, the share prices aren’t commensurate with their intrinsic or real values.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Dividend Stocks

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »

coins jump into piggy bank
Dividend Stocks

The Smartest Dividend Stocks to Buy With $500 Right Now

These top dividend stocks both offer attractive yields and trade off their highs, making them two of the best to…

Read more »

Middle aged man drinks coffee
Dividend Stocks

Here’s the Average TFSA Balance at Age 35 in Canada

At age 35, it might not seem like you need to be thinking about your future cash flow. But ideally,…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

How to Invest Your $7,000 TFSA Contribution in 2024

Here's how I would prioritize a $7,000 TFSA contribution for growth and income.

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

CPP Pensioners: Watch for These Important Updates

The CPP is an excellent tool for retirees, but be sure to stay on top of important updates like these.

Read more »

Technology
Dividend Stocks

TFSA Investors: 3 Dividend Stocks I’d Buy and Hold Forever

These TSX dividend stocks are likely to help TFSA investors earn steady and growing passive income for decades.

Read more »

four people hold happy emoji masks
Dividend Stocks

Love Dividend Growth? Check Out These 2 Income-Boosting Stocks

National Bank of Canada (TSX:NA) and another Canadian dividend-growth stock are looking like a bargain going into December 2024.

Read more »

An investor uses a tablet
Dividend Stocks

A Dividend Giant I’d Buy Over Enbridge Stock Right Now

Enbridge stock may seem like the best of the best in terms of dividends, but honestly this one is far…

Read more »